Latest News

Jeffrey M. Dayno, MD  (Credit: LinkedIn)
FDA Approves Pitolisant for Excessive Daytime Sleepiness in Pediatric Narcolepsy

June 24th 2024

Pitolisant is the first and only drug in the class of antagonist/reverse agonists of the histamine H3 receptor for the treatment of patients with narcolepsy.

This Week on NeurologyLive® — June 24, 2024
This Week on NeurologyLive® — June 24, 2024

June 24th 2024

Anissa Mitchell, LCSW  (Credit: PMD Alliance)
Survey Reveals Barriers to Symptom and Concern Disclosure in Movement Disorders

June 23rd 2024

Cindy Happel, RN, BSN  (Credit: LinkedIn)
Apokyn Initiation Without Antiemetic Prophylaxis Does Not Affect Tolerability in Parkinson Disease

June 23rd 2024

Aaron L. Ellenbogen, DO, MPH, FACN  (Credit: MIND)
ND0612 Reduces OFF Time for Motor Fluctuations in Parkinson Disease at 12 Months

June 23rd 2024

Coverage of SLEEP 2024

Get the latest data and clinical news updates, as well as interviews with experts, straight from the conference floor of SLEEP 2024.

SLEEP 2024

Conference Coverage

View All
Role of Sleep Chronotype, Circadian Rhythm in Neurocognitive Health: Ashley Curtis, PhD
Role of Sleep Chronotype, Circadian Rhythm in Neurocognitive Health: Ashley Curtis, PhD

June 22nd 2024

Understanding the Importance of Maternal-Fetal Circadian Synchrony
Understanding the Importance of Maternal-Fetal Circadian Synchrony

June 20th 2024

Treatment Decisions With Stable Multiple Sclerosis
Treatment Decisions With Stable Multiple Sclerosis

June 19th 2024

Switching From S1P-Modulating Therapies to Other DMTs
Switching From S1P-Modulating Therapies to Other DMTs

June 19th 2024

Video Series
Video Interviews
Podcasts

Most Recent

© 2024 MJH Life Sciences

All rights reserved.